education
Download App
Indonesia
search
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Country
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Other Services
Education
Download App
Country
Indonesia
Hong Kong
India
Indonesia
Malaysia
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
Account
Masuk
Home
Find Drugs
Pill Identifier
Find Drug Company
Diseases
Medical News & Updates
Iklan
Iklan
MIMS home
Drugs
Info
Farmasal
Farmasal
aspirin
Manufacturer:
Fahrenheit
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Bahasa Concise Prescribing Info
Concise Prescribing Info
Contents
ASA
Indications/Uses
Antiaggregant treatment in pathological condition in which platelet hyperactivity or activation may be determinant factor in the formation of thrombi.
Dosage/Direction for Use
1 tab daily.
Administration
Should be taken with food: Swallow whole, do not chew/crush.
Contraindications
Peptic ulcer or dyspepsia. Bleeding disorders, asthma. Infant.
Special Precautions
Porphyria. Impaired renal or hepatic function. Pregnancy & lactation. Childn.
Adverse Reactions
Gastric irritation. Hypothrombinaemia, dizziness, tinnitus, hypersensitivity reactions.
View
ADR Reporting Link
Drug Interactions
Enhance effects of anticoagulants & inhibits action of uricosurics.
MIMS Class
Anticoagulants, Antiplatelets & Fibrinolytics (Thrombolytics)
ATC Classification
B01AC06 - acetylsalicylic acid ; Belongs to the class of platelet aggregation inhibitors excluding heparin. Used in the treatment of thrombosis.
Regulatory Classification
B
Presentation/Packing
Form
Farmasal enteric-coated tab 100 mg
Packing/Price
10 × 10's (Rp44,000/boks)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk
Daftar Gratis untuk melanjutkan membaca
Lanjutkan dengan Google
Daftar dengan email
Sudah punya akun?
Masuk